Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of the Guardant ...

Just days after Lydia Dutcher gave birth to her son Theo, she learned she had a tumor in her placenta and was diagnosed with ...

As National Women’s Health Week approaches, new global data highlighting projected rises in breast and ovarian cancer through ...

This new immunotherapy is particularly effective in several types of solid tumors, but it will take time to confirm its ...

The Wee1 inhibitor adavosertib shows activity in recurrent uterine serous carcinoma, but the drug’s tolerability remains a ...

A study of more than 100 patients found that immunotherapy can cure a rare type of cancer in various tumor sites without ...

“At our corporate R&D event, we reported positive updated interim data from our ongoing ACR-368 Phase 2b study in endometrial cancer patients with large tumors and aggressive histopathologies ...

Cancer before age 50 is rare, but increasing, in the United States and researchers want to know why.

Faeth Therapeutics, a clinical-stage biotechnology company integrating precision nutrition with combination therapies to ...

Overall, rates of new cancer diagnoses and cancer-related deaths have declined, according to the annual cancer statistics report from the National Cancer Institute.

Naiké Vorbe experienced abdominal pain, constipation, and diarrhea. She learned at 31 that she had stage 3 colon cancer.